Primary malignant vaginal melanoma (PMVM) is a rare and aggressive subtype of mucosal melanoma with poor prognosis and lack of standardised management guidelines. We report a case of a postmenopausal ...

Adjuvant chemotherapy was associated with substantially longer median overall survival (28 vs 10 months) in patients undergoing pelvic exenteration for gynecologic cancers with pelvic lymph node ...

HHS unveiled a new Alzheimer's and dementia plan in Fort Lauderdale focused on prevention and early detection. Here is what is promised and proven. Final CDC Data Put U.S. Fertility Rate at Record Low ...

Pelvic exenteration represents one of the most radical surgical interventions in oncological practice, aimed at achieving complete tumour clearance in locally advanced or recurrent pelvic malignancies ...

Interim analysis of a single-arm, phase II study of bevacizumab (BV) with modified OPTIMOX1 as first-line treatment of patients with metastatic colorectal cancer (mCRC): TCOG-GI0802. Outcomes of ...

IT has been established that removal of all the pelvic viscera can be accomplished with a mortality of 25 per cent or less and that the resultant physiologic readjustments permit a comfortable and ...

A large 10-year series from a single-site institution in the United Kingdom of vulva carcinoma: An audit on adherence of United Kingdom guidelines and overall survival. Results of a randomized phase ...

You never know what will remain in people's memories. In my case, it seems it was my internal organs.Last May, I underwent a ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...

Patients with cancers of the abdomen and pelvis which were previously thought to be inoperable are now surviving long term thanks to developments in surgical techniques, according to a study. Research ...

A cancer patient who had to have all the organs within her pelvis removed is at the centre of a research project designed to improve future treatments. Sharon Applin, 58, from Wimborne, Dorset, is ...